Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing.
about
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistanceReal-Time PCR: Revolutionizing Detection and Expression Analysis of GenesReal-time PCR in clinical microbiology: applications for routine laboratory testing.Inactivation of the inhA-encoded fatty acid synthase II (FASII) enoyl-acyl carrier protein reductase induces accumulation of the FASI end products and cell lysis of Mycobacterium smegmatisThe molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosisThiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosisMethodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other MycobacteriaGenomic stability over 9 years of an isoniazid resistant Mycobacterium tuberculosis outbreak strain in SwedenMultidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testingMycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosisMolecular approaches for detection of the multi-drug resistant tuberculosis (MDR-TB) in BangladeshDetection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon SequencingAdvances in the diagnosis and treatment of tuberculosis.Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study.Development of a molecular-beacon assay to detect the G1896A precore mutation in hepatitis B virus-infected individuals.Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technologyMolecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphismRapid detection of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis by high-resolution melting analysisIdentification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis.Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol.Diagnostic Performance of the GenoType MTBDRplus and MTBDRsl Assays to Identify Tuberculosis Drug Resistance in Eastern China.Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-specific PCR assay targeting katG codon 315 variationRapid identification of Candida dubliniensis using a species-specific molecular beacon.Detection of rifampin resistance in Mycobacterium tuberculosis in a single tube with molecular beacons.Use of molecular beacons to detect an antifolate resistance-associated mutation in Plasmodium falciparumNovel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in AustraliaHigh prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001.Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans.Detection of mutations associated with isoniazid resistance in Mycobacterium tuberculosis isolates from China.Changing approaches to the diagnosis of tuberculosis.Molecular beacons: nucleic acid hybridization and emerging applications.Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis.Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesis.Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis clinical isolates in Lithuania.Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunitiesPerformance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance.Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.
P2860
Q22241307-D446150F-F0AF-4E3F-B7DA-3DB8E2A1834AQ24653633-14759D9A-3496-4D07-9539-28D8D1541739Q27472851-8D16432D-C77E-4F73-94CF-D3DF6B51CC87Q28344391-D5D793F2-5467-4740-AE8C-E0A603CA93EEQ28362898-C86B557C-1C01-42E0-8F3B-5BB49F8941D1Q28375163-C7950758-D346-4169-BF33-EBC203D04E62Q28389409-903F4BBE-967C-44A3-A634-B66DA448FAD7Q28477040-F504C13D-36E1-4F70-BD5E-76A1EA8B2D34Q28485230-8035ED1D-D44D-42E2-8EB7-74FBB25C3A97Q28487401-21AA6E3C-E9D3-47D7-A96D-D24A249FF559Q28539727-4B5F8A6F-7D3D-4F5C-BA84-538D97A6207EQ28547220-795982FF-E4E8-4365-8A12-58FE737D9078Q30353049-F3DBE360-53DD-462C-AEC8-9143A0EB6A2EQ33534907-A2B7F053-7F15-4B2C-82A3-2EDF1D3FD1A2Q33592384-CA16A2FF-8B65-4222-A0BF-21BCEA12FC97Q33614228-F85A2DB1-637D-479B-9D18-A9C13173EB0FQ33722028-F72E0667-E2C0-4499-B0B6-9E2DC5BACD64Q33769559-5A515403-D33A-4912-B826-7C06D8250DA5Q33826352-77B51D5E-55C5-4F01-BEDD-FA57CE202AF2Q33836636-7D408348-710C-4D4F-89FD-68BD83F3453EQ33864689-A370077C-C991-4F0D-81FC-6B2FA1106B06Q33961266-8041548A-7CEF-4402-B4B8-F01CDAB0E909Q33968704-CD7F5A50-CD33-4834-9FE4-C9CB7AE75171Q33974090-2D10359B-3A3A-4503-8265-F0642ABFF081Q33981071-FFEBCD24-523B-4D07-9400-61398F530DD7Q33982614-5A525809-71B9-41EB-9ABF-2274CAFA68D5Q34041549-4EC561B1-94EA-4F9B-9D41-280B05D4D2F8Q34077090-DA82AE34-E831-4F0E-881A-D2B483B7250BQ34107006-BF6EDC85-1E74-4E1A-9992-72E91DEAE526Q34131132-02195A1D-CFA6-4199-9E2C-159EC14360AEQ34143763-B5E1862D-6EC1-4D6B-8ED6-58A6E0D8149FQ34460809-E602E23D-708F-4470-8F39-E7FCE7BF865BQ34492587-E38A8D59-A5D6-4BAB-A871-D89129EA48E0Q34492662-65B65E84-5D57-4376-9209-4A37BCA66A26Q34973711-732E7C26-57A4-4B33-B7C2-742DFB48DC23Q35006529-C5D2FC7F-F0E1-4C98-878D-880BCC3FE83DQ35014210-29E7B647-A2A7-488B-AB5F-A0DCDB1E3A75Q35066020-644FCADC-80C2-4107-ABDC-149FC6B23763Q35073562-EEC5EFB7-4EBF-4DAA-B715-3BA871D1B6A6Q35909558-2586B3A9-5A90-4B49-8896-038B91B0A8E6
P2860
Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Genotypic analysis of Mycobact ...... rapid susceptibility testing.
@ast
Genotypic analysis of Mycobact ...... rapid susceptibility testing.
@en
type
label
Genotypic analysis of Mycobact ...... rapid susceptibility testing.
@ast
Genotypic analysis of Mycobact ...... rapid susceptibility testing.
@en
prefLabel
Genotypic analysis of Mycobact ...... rapid susceptibility testing.
@ast
Genotypic analysis of Mycobact ...... rapid susceptibility testing.
@en
P2093
P2860
P1476
Genotypic analysis of Mycobact ...... rapid susceptibility testing.
@en
P2093
A S Piatek
F R Kramer
M R Murray
W R Jacobs
P2860
P304
P356
10.1128/AAC.44.1.103-110.2000
P407
P577
2000-01-01T00:00:00Z